Slim, Sane, and Sexy

New Book Released on Bioidentical Hormone Replacement Therapy

Slim, Sane, and Sexy- authored by Jay H. Mead and Erin Lommen, ND

http://www.slimsaneandsexy.com

If you are looking for a safe and scientifically sound method of hormone replacement, this is the book that will answer your questions and guide you to sources for testing, treatment, and further information. While there are many books on menopause and hormones, most provide only partial or even potentially dangerous solutions. Slim, Sane, and Sexy offers safe, research-based treatments and recommendations for correcting hormone imbalances. Bioidentical hormone replacement therapy, along with wholesome lifestyle habits offers women a safe, effective alternative to conventional, or synthetic HRT. Physicians Drs. Mead and Lommen have helped thousands of women reclaim their lives using the methods outlined in this simple to follow guide for you and your physician. Add years to your life and feel better than ever—for the rest of your life!

Whatever your interest or motivation, Slim, Sane, and Sexy offers straight talk about what you’re experiencing and what you can do about it. If hormone imbalance is causing your symptoms, this natural hormone guide can put you back in the driver’s seat, allowing you to maintain healthy weight, steady emotions, and sustained energy.

About the Authors

Jay H. Mead MD, FASCP, is the President and Medical Director of Labrix Clinical Services, Inc a laboratory providing innovative testing for discerning practitioners. He is a leading expert in Salivary hormone and Urine iodine testing. Dr. Mead has been practicing as a clinician for over twenty years and understands the need and value of accurate, reliable laboratory testing. Dr. Mead is a board certified pathologist (AP/CP), a retired USAF Flight Surgeon and cofounder of a progressive full service complementary and alternative medical clinic. He also has board certification in blood banking and lead the Pacific Northwest Region of the American Red Cross as the Chief Medical Officer for over 10 years. Dr Mead is the co-author of the book: Slim, Sane and Sexy; Pocket Guide to Natural, Bioidentical Hormone Balancing (available May/June 2008 Calaroga Publishing).

Dr. Lommen is a licensed Naturopathic Physician and is enjoying her 19th year of clinical family practice and health optimization through anti-aging practices. She was a clinical investigator for a successful 5-year study through the NIH (National Institute of Health) on chronic disease. Dr Lommen has taught as an associate professor at NCNM (National College of Naturopathic Medicine) for 10 years. Dr Lommen is the CEO and Assoc. medical director of Labrix Clinical Services Inc. She is the co-author of the book: Slim, Sane and Sexy; Pocket Guide to Natural, Bioidentical Hormone Balancing (June 2008 Calaroga Publishing). Dr Lommen has spoken at National conferences on topics including: Adrenal Health, GI Health, Bioidentical Hormone Balancing, PCOS and Metabolic Syndrome, Depression and Chronic Fatigue Syndrome. Television interviews include both local and national stations, most notably; CNN.

The treatment modalities she employs in her practice are: bioidentical hormones, nutrition, vitamin and mineral replacement, mind/body and lifestyle counseling, botanical medicine, liver cleansing and detoxification.

Physicians: Oppose Wyeth & FDA Actions to Limit Prescribing!

Source: Patients and Professionals for Customized Care

As you may be aware, FDA made a horrible decision on January 9, 2008—choosing Wyeth’s wealth over patient health. FDA agreed to support Wyeth in their campaign to end access to compounded hormone replacement therapies—specifically by starting a crackdown on the use of estriol, which FDA is claiming to be illegal.

FDA also stated that pharmacies must stop using the term bio-identical. IACP is unequivocally opposed to FDA’s efforts to restrict the use of estriol and believes the use of the term “bio-identical” is appropriate.

Be assured that you are on the right side of this issue:

• Hundreds of thousands of patients—perhaps millions—currently benefit from compounded hormone replacement therapy as prescribed by their physicians. For many of these patients, these medications have been their only source of relief and health from symptoms of menopause and perimenopause. We are not aware of any evidence, clinical or otherwise, to suggest that these women should have their therapies stripped from them.
  
  
• In a press conference, FDA admitted there was not a single instance of an adverse event related to estriol that has been reported to FDA.
  
  
• Estriol has a USP monograph. It is recognized by USP. For a pharmacy to compound estriol pursuant to a valid prescription is consistent with USP standards (chapters 795 and 1075), the Pharmacy Compounding Accreditation Board’s standards, and state pharmacy law. Congress specifically recognized and approved the use of active ingredients that have a USP monograph as appropriate for use in compounding.
  
  
• There is currently an estriol product in phase III clinical trials for the treatment of Multiple Sclerosis. The safety data thus far has allowed the trials to continue to proceed.
  
  
• Estriol has been used in Asia and Europe for years. Its use is well-supported in medical literature.
  
  
• The use of the term bio-identical is an accurate descriptor of what these estrogens are. FDA-registered manufacturers use the term on their websites to describe FDA-approved estrogen and progesterone products.

From both a clinical and legal point of view, the evidence supporting our position for compounded bio-identical hormone replacement therapy as a continued option in women's health is compelling. FDA is wrong. It is in the best interest of patients to continue to receive the medications they are prescribed.

Do you want to learn more and see how you can help? Visit P2C2